Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes

Muriel Ghosn, Nizar Attallah, Mohamed Badr, Khaled Abdallah, Bruno De Oliveira, Nadeem Ashraf, Yeldho Varghese, Dnyaseshwar Munde, Shameen Salam, Baraa Abduljawad, Khaled Saleh, Hussam Elkambergy, Ali S. Wahla, Ahmed Reda Taha, Jamil Dibu, Ahmed Bayrlee, Fadi Hamed, Nadeem Rahman, Jihad MallatJournal of Clinical Medicine 2021 · DOI

TL;DR

This study investigated severe acute kidney injury (AKI) in critically ill COVID-19 patients, finding it to be common (45.4%) and independently associated with increased hospital mortality and longer hospital stays. Notably, inflammatory and thrombotic markers were not found to be risk factors, suggesting a different underlying mechanism than initially hypothesized.

What Problem Does This Paper Address?

The COVID-19 pandemic has placed immense strain on healthcare systems worldwide, with a significant proportion of critically ill patients requiring intensive care unit (ICU) admission due to acute respiratory failure. A concerning complication observed in these patients is acute kidney injury (AKI), particularly severe AKI (defined by KDIGO stages 2 or 3). While AKI is a known risk factor for mortality in critically ill patients generally, its specific incidence, risk factors, and prognostic impact in the context of COVID-19, especially in the ICU setting, remained less clear. This paper aims to fill this knowledge gap by examining these aspects in a cohort of critically ill COVID-19 patients admitted to the ICU.

Methods

This was a retrospective, monocenter study conducted at Cleveland Clinic Abu Dhabi. The researchers analyzed data from adult patients admitted to the ICU between March and May 2020 who had confirmed SARS-CoV-2 infection and presented with acute respiratory failure. Severe AKI was defined according to KDIGO criteria (stages 2 or 3). The primary outcome was to determine the incidence and risk factors associated with severe AKI. Secondary outcomes included the association of severe AKI with hospital mortality, ICU length of stay, hospital length of stay, and mechanical ventilation duration. Statistical analyses included univariate comparisons, multivariable logistic regression to identify independent risk factors for severe AKI and hospital mortality, and competing-risks regression for hospital length of stay.

Datasets

The study utilized data collected from 110 adult patients admitted to the ICU at Cleveland Clinic Abu Dhabi between March 1 and May 29, 2020. This dataset included demographic information, physiological variables, comorbidities, severity scores (SOFA and SAPS II), laboratory values (including inflammatory and thrombotic markers), and treatment details during their ICU stay.

Key Insights and Ideas

  • Severe AKI is a significant problem in critically ill COVID-19 patients: The high incidence (45.4%) highlights that AKI is not a rare complication but a common and serious one in this population.
  • Inflammatory and thrombotic markers are not the primary drivers of severe AKI in this context: This finding challenges some initial hypotheses about the "cytokine storm" and hypercoagulability directly causing AKI in COVID-19, suggesting other mechanisms might be at play.
  • Age, baseline kidney function, and mechanical support are key risk factors: The independent association of older age, higher creatinine levels on admission, invasive mechanical ventilation, and extracorporeal membrane oxygenation points towards factors that compromise kidney function or increase its workload.
  • Severe AKI is a strong predictor of poor outcomes: The independent association with higher hospital mortality and longer hospital stays underscores the clinical importance of recognizing and managing severe AKI promptly.
  • Renal recovery is possible: A notable finding is that a significant majority (74.1%) of patients with severe AKI who were discharged alive recovered normal or baseline renal function, offering a glimmer of hope for survivors.

Key Results

  • Incidence of Severe AKI: 50 out of 110 patients (45.4%) developed severe AKI (KDIGO stages 2 or 3).
  • Independent Risk Factors for Severe AKI: Age (OR = 1.08), invasive mechanical ventilation (OR = 33.44), creatinine level on admission (OR = 1.04), and extracorporeal membrane oxygenation (OR = 11.42) were independently associated with severe AKI.
  • Association with Hospital Mortality: Severe AKI was independently associated with a significantly higher hospital mortality (OR = 29.73).
  • Association with Hospital Length of Stay: Severe AKI was independently associated with a longer hospital length of stay (SHR = 0.26).
  • Renal Recovery: Among patients discharged alive, 74.1% recovered normal or baseline renal function.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: This inherent limitation means potential for selection bias and reliance on existing data.
  • Single-Center Study: The findings may not be generalizable to other healthcare settings or populations.
  • Missing Baseline Creatinine: In 60% of cases, baseline creatinine was not available, necessitating the use of admission creatinine as a proxy. While the authors argue this is unlikely to significantly overestimate AKI incidence in their cohort, it remains a potential source of bias.
  • Unaccounted Nephrotoxins: The study did not include data on the use of nephrotoxic agents, which could be a confounding factor.

Future work suggested includes prospective studies to confirm these findings and further investigate the specific pathophysiological mechanisms underlying AKI in COVID-19, particularly given the unexpected lack of association with inflammatory and thrombotic markers.

Summary updated

Abstract

Severe AKI was common in critically ill patients with COVID-19 and was not associated with inflammatory or thrombotic markers. Severe AKI was an independent risk factor of hospital mortality and hospital length of stay, and it should be rapidly recognized during SARS-CoV-2 infection.
BibTeX
@article{ghosn2021severe,
  author = {Muriel Ghosn and Nizar Attallah and Mohamed Badr and Khaled Abdallah and Bruno De Oliveira and Nadeem Ashraf and Yeldho Varghese and Dnyaseshwar Munde and Shameen Salam and Baraa Abduljawad and Khaled Saleh and Hussam Elkambergy and Ali S. Wahla and Ahmed Reda Taha and Jamil Dibu and Ahmed Bayrlee and Fadi Hamed and Nadeem Rahman and Jihad Mallat},
  title = {{Severe Acute Kidney Injury in Critically Ill Patients with COVID-19 Admitted to ICU: Incidence, Risk Factors, and Outcomes}},
  journal = {Journal of Clinical Medicine},
  year = {2021},
  doi = {10.3390/jcm10061217},
}
Figure